Kinfo
Eli Lilly and Company logo

Eli Lilly and Company

LLYNYSEHealthcare·US · USD
$1,163.00
+20.15 (+1.76%)
Prices as of October 5, 2026 · live

Price

Key statistics

Valuation
Market cap1.02T USD
Enterprise value1.06T USD
Trailing P/E38.36
Forward P/E24.01
PEG ratio1.46
Price / sales12.79
Price / book30.07
Profitability
Gross margin85.78%
Operating margin54.22%
Profit margin33.53%
Return on assets20.36%
Return on equity102.29%
Income (TTM)
Revenue79.67B USD
Gross profit66.44B USD
EBITDA49.25B USD
Net income26.71B USD
Diluted EPS$29.79
Rev. growth (YoY)47.70%
Balance sheet
Total cash8.95B USD
Total debt54.91B USD
Debt / equity162.07
Current ratio1.36
Book value / share$38.00
Cash flow (TTM)
Operating cash flow28.08B USD
Levered free cash flow11.07B USD
Shares & price
Shares outstanding891.50M
Float888.95M
Held by institutions85.30%
Beta0.50
50-day MA$1,176.79
200-day MA$1,073.81
52-week high$1,292.65
52-week low$783.85
Dividends
Forward rate
$6.92
Yield
0.60%
Payout ratio
21.69%
Frequency
Quarterly
Recent payments
  • 2026-08-14$1.73
Earnings (EPS)
DateEst.ActualSurprise2026-08-056.588.38+27.36%2026-04-306.798.55+25.92%2026-02-046.917.54+9.12%2025-10-305.897.02+19.19%2025-09-140.03-0.02−166.67%
About Eli Lilly and Company

Eli Lilly and Company is a global medicine company focused on discovering, developing, manufacturing, and marketing human pharmaceutical products. Eli Lilly and Company operates across major therapeutic areas including diabetes, obesity, oncology, immunology, neuroscience, and cardiovascular care, serving patients, healthcare providers, and health systems worldwide. Its current portfolio includes widely used treatments for chronic metabolic conditions as well as therapies for cancer and immune-related diseases, supported by ongoing commercial operations and regulated manufacturing capacity in the United States, Europe, and Asia. The company also advances diagnostics and specialty medicines that address complex medical needs in hospital, outpatient, and community settings. Eli Lilly and Company plays a significant role in the pharmaceutical market through its broad product lineup, large-scale distribution network, and focus on prescription medicines that are used in everyday clinical practice.

Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Mr. David A. Ricks
Employees
50,000
Headquarters
Indianapolis, IN, United States

Frequently asked questions about Eli Lilly and Company